Innovation Fusion, Infinite Leap
From April 8 to 12, the 93rd China International Medical Equipment Fair (CMEF) was grandly held at the National Exhibition and Convention Center (Shanghai). As a weathervane of the global healthcare industry, this exhibition gathered nearly 5,000 enterprises from more than 30 countries and regions worldwide, showcasing the latest achievements in medical technology, artificial intelligence, brain-computer interfaces, medical robots and other fields.
As a professional manufacturer specializing in hemodialysis equipment, Bain Medical made its debut at the CMEF booth with two new dialysis models, DORA-6000S and DORA-6000R. Featuring cutting-edge technologies and differentiated functions, the products drew extensive attention from domestic and overseas distributors, clinical experts and industry peers.
Focus on the 15th Five-Year Plan, Embrace Industrial Leap
This edition of CMEF coincides with the inaugural year of the 15th Five-Year Plan, with the theme Infinite Leap directly targeting industrial upgrading and digital-intelligent integration. Guided by core development directions including AI-enabled healthcare, the silver economy and smart health, Bain Medical proactively responds to policy guidance and market demands.
As an essential treatment for patients with end-stage renal disease, hemodialysis is evolving at an accelerated pace toward intelligence, precision and humanization. The new DORA series not only fully demonstrates the company’s robust R&D capabilities, but also caters to the industry’s in-depth demands for consumable-free operation, cost reduction and efficiency improvement.
New Product Launch, Strength Wins Wide Acclaim
At Booth 6.2D10, the newly launched DORA series of hemodialysis devices drew crowds of professional visitors who stopped for in-depth inquiries upon its debut.
Core Highlights at a Glance, Redefining the Dialysis Experience
✅ Four built-in monitoring functions：Real-time surveillance of core parameters during dialysis treatment, reinforcing clinical safety barriers and keeping pace with the development trend of AI- enabled precision medical treatment.；
✅ AOS™ A-POWDER ONLINE SYSTEM：Overcomes the limitations of conventional dialysate preparation, enhances therapeutic efficiency and operational stability, and highlights independent innovative breakthroughs in domestic medical technology；
✅ Saline-free priming：Streamlines clinical workflows, cuts down treatment preparation time, and reduces the consumption of medical consumables.；
✅ Automatic bidirectional blood priming and blood return：Improves intelligent operation performance, reduces manual operation by medical staff, and minimizes clinical operational risks.
The launch of these two new products represents not only the transformation of Bain Medical’s technological accumulation over the years, but also a precise response to the core demands for intelligence, high efficiency and safety in the current hemodialysis sector.
As China’s hemodialysis equipment market ushers in explosive growth in 2026, the expansion of primary healthcare services and the development of out-of-hospital dialysis scenarios have emerged as new industry opportunities. The DORA series hemodialysis devices will deliver cost-effective domestic solutions for medical institutions at all levels.
Bain Medical achieved fruitful results from this exhibition:
Brand Strength Demonstrated
By launching new products for the first time on the international stage of CMEF, the Company fully presents its technical accumulation and sustained innovation capabilities in the field of hemodialysis equipment, further enhancing brand awareness and industrial influence.
Insight into Cutting-edge Trends
Through in-depth exchanges with global counterparts and technical experts, the Company gains profound insights into emerging directions including AI-assisted diagnosis and treatment, remote dialysis management and integrated rehabilitation, providing critical references for subsequent product iteration and advanced technology research.
The successful conclusion of the 93rd CMEF marks a new starting point for Bain Medical’s in-depth dedication to the hemodialysis sector. Moving forward, we will continue to be driven by Innovation Fusion, focus on digital intelligence and full-industry-chain integration, and steadily scale up R&D investment. We will advance the upgrading of domestic hemodialysis equipment toward higher precision and greater intelligence, and deliver safer, more efficient and more convenient treatment solutions for renal patients worldwide.